Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (2024)

Table of Contents
Latest LH Messages Labcorp News

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials

Addition of pTau217 test further expands thecompany's leadership in testing options for Alzheimer's disease toimprove patient care

BURLINGTON, N.C., March 20,2024 /PRNewswire/ -- Labcorp(NYSE: LH), aglobal leader of innovative and comprehensive laboratory services,announced today the launch and immediate availability of its testto identify the presence or absence of phosphorylated tau 217(pTau217), a pivotal blood biomarker designed to aid in thediagnosis of Alzheimer's disease and the subsequent monitoring ofpatients undergoing treatment with new Alzheimer's diseasetherapies. Labcorp's pTau217 test can be ordered by physicians andused in clinical trials and research by global biopharmaceuticalpartners.

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (1)

Alzheimer's disease, the most prevalent form of dementia, posesa significant health challenge globally. An estimated 6.7 millionAmericans are currently living with Alzheimer's disease, a figureprojected to more than double to 13.8 million individuals by 2060.The pTau217 marker has been used in Alzheimer's drug trials tomonitor patients on anti-amyloid therapy.

Labcorp's introduction of pTau217 as a standalone test marks asignificant advancement in the company's Alzheimer's testingportfolio, complementing its existing array of blood-basedbiomarker testing, including:

  • Betaamyloid 42/40 ratio, which provides an indication ofamyloid pathology for Alzheimer's disease and is availablenationwide for clinicians and available in Europe as a CE-marked assay.
  • Neurofilament light chain (NfL), which provides an indicationof disease severity by measuring current levels ofneurodegeneration.
  • ATN Profile, which combines three blood biomarkers – betaamyloid 42/40, NfL and pTau181. The ATN Profile provides physicianswith an accessible and interpretable blood test to assesspathologies associated with Alzheimer's disease and otherneurodegenerative conditions, which can help accelerate the path todiagnosis and intervention.

"The introduction of pTau217 represents a significant milestonein our ongoing commitment to advancing testing capabilities acrossthe spectrum of Alzheimer's disease," said Dr.BrianCaveney,Labcorp'sChief Medical and Scientific Officer."By expanding our suite of blood-based biomarker tests, we areempowering clinicians and pharma with more tools for clinicaltrials and for the detection and monitoring of Alzheimer's toimprove patient care."

For more information about the pTau217 biomarker and the use ofLabcorp's new test in patient care, visithttp://www.labcorp.com/alzheimers.

For biopharma laboratory services inquiries, please visithttps://www.labcorp.com/neurology/neurodegenerative-diseases/pharmaceutical-partners.

About Labcorp
Labcorp (NYSE: LH) is a global leader ofinnovative and comprehensive laboratory services that helpsdoctors, hospitals, pharmaceutical companies, researchers andpatients make clear and confident decisions. We provide insightsand advance science to improve health and improve lives through ourunparalleled diagnostics and drug development laboratorycapabilities. The company's more than 67,000 employees serveclients in over 100 countries, worked on over 84% of the new drugsapproved by the FDA in 2023 and performed more than 600 milliontests for patients around the world. Learn more about us atwww.labcorp.com.

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (2)View original content to downloadmultimedia:https://www.prnewswire.com/news-releases/labcorp-launches-ptau217-blood-biomarker-test-to-accelerate-path-to-diagnosis-of-alzheimers-disease-and-support-clinical-trials-302094433.html

SOURCE Labcorp

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (3)

Copyright 2024 PR Newswire

Labcorp (NYSE:LH)
Historical Stock Chart
From Apr 2024 to May 2024

Labcorp (NYSE:LH)
Historical Stock Chart
From May 2023 to May 2024

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (6){{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}}
  • Share on Facebook Share on Twitter Share on Email

Loading Messages....

No posts yet, be the first!No LH Message Board. Create One!See More Posts on LH Message BoardSee More Message Board Posts

Labcorp News

Loading Messages....

`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `

`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `

No News, be the first to add your company releases.

`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Form S-8 - Securities to be offered to employees in employee benefit plans","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882944\/form-s-8-securities-to-be-offered-to-employees-i","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715979437,"date":"Fri May 17, 2024 ","time":"4:57 PM (4 days ago)","full_date":"May 17, 2024 4:57 PM","post_time":"May 17 2024","article_id":93882944,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882777\/form-s-3asr-automatic-shelf-registration-stateme","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715978726,"date":"Fri May 17, 2024 ","time":"4:45 PM (4 days ago)","full_date":"May 17, 2024 4:45 PM","post_time":"May 17 2024","article_id":93882777,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form POSASR - Post-effective Amendment to an automatic shelf registration statement","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882717\/form-posasr-post-effective-amendment-to-an-autom","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715978489,"date":"Fri May 17, 2024 ","time":"4:41 PM (4 days ago)","full_date":"May 17, 2024 4:41 PM","post_time":"May 17 2024","article_id":93882717,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882526\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977951,"date":"Fri May 17, 2024 ","time":"4:32 PM (4 days ago)","full_date":"May 17, 2024 4:32 PM","post_time":"May 17 2024","article_id":93882526,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882501\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977887,"date":"Fri May 17, 2024 ","time":"4:31 PM (4 days ago)","full_date":"May 17, 2024 4:31 PM","post_time":"May 17 2024","article_id":93882501,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882416\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977739,"date":"Fri May 17, 2024 ","time":"4:28 PM (4 days ago)","full_date":"May 17, 2024 4:28 PM","post_time":"May 17 2024","article_id":93882416,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882404\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977706,"date":"Fri May 17, 2024 ","time":"4:28 PM (4 days ago)","full_date":"May 17, 2024 4:28 PM","post_time":"May 17 2024","article_id":93882404,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882398\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977661,"date":"Fri May 17, 2024 ","time":"4:27 PM (4 days ago)","full_date":"May 17, 2024 4:27 PM","post_time":"May 17 2024","article_id":93882398,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882378\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977620,"date":"Fri May 17, 2024 ","time":"4:27 PM (4 days ago)","full_date":"May 17, 2024 4:27 PM","post_time":"May 17 2024","article_id":93882378,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882314\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977418,"date":"Fri May 17, 2024 ","time":"4:23 PM (4 days ago)","full_date":"May 17, 2024 4:23 PM","post_time":"May 17 2024","article_id":93882314,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882307\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977382,"date":"Fri May 17, 2024 ","time":"4:23 PM (4 days ago)","full_date":"May 17, 2024 4:23 PM","post_time":"May 17 2024","article_id":93882307,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882301\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977347,"date":"Fri May 17, 2024 ","time":"4:22 PM (4 days ago)","full_date":"May 17, 2024 4:22 PM","post_time":"May 17 2024","article_id":93882301,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Form S-8 - Securities to be offered to employees in employee benefit plans","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882944\/form-s-8-securities-to-be-offered-to-employees-i","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715979437,"date":"Fri May 17, 2024 ","time":"4:57 PM (4 days ago)","full_date":"May 17, 2024 4:57 PM","post_time":"May 17 2024","article_id":93882944,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882777\/form-s-3asr-automatic-shelf-registration-stateme","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715978726,"date":"Fri May 17, 2024 ","time":"4:45 PM (4 days ago)","full_date":"May 17, 2024 4:45 PM","post_time":"May 17 2024","article_id":93882777,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form POSASR - Post-effective Amendment to an automatic shelf registration statement","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882717\/form-posasr-post-effective-amendment-to-an-autom","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715978489,"date":"Fri May 17, 2024 ","time":"4:41 PM (4 days ago)","full_date":"May 17, 2024 4:41 PM","post_time":"May 17 2024","article_id":93882717,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882526\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977951,"date":"Fri May 17, 2024 ","time":"4:32 PM (4 days ago)","full_date":"May 17, 2024 4:32 PM","post_time":"May 17 2024","article_id":93882526,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882501\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977887,"date":"Fri May 17, 2024 ","time":"4:31 PM (4 days ago)","full_date":"May 17, 2024 4:31 PM","post_time":"May 17 2024","article_id":93882501,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882416\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977739,"date":"Fri May 17, 2024 ","time":"4:28 PM (4 days ago)","full_date":"May 17, 2024 4:28 PM","post_time":"May 17 2024","article_id":93882416,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882404\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977706,"date":"Fri May 17, 2024 ","time":"4:28 PM (4 days ago)","full_date":"May 17, 2024 4:28 PM","post_time":"May 17 2024","article_id":93882404,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882398\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977661,"date":"Fri May 17, 2024 ","time":"4:27 PM (4 days ago)","full_date":"May 17, 2024 4:27 PM","post_time":"May 17 2024","article_id":93882398,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882378\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977620,"date":"Fri May 17, 2024 ","time":"4:27 PM (4 days ago)","full_date":"May 17, 2024 4:27 PM","post_time":"May 17 2024","article_id":93882378,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882314\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977418,"date":"Fri May 17, 2024 ","time":"4:23 PM (4 days ago)","full_date":"May 17, 2024 4:23 PM","post_time":"May 17 2024","article_id":93882314,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882307\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977382,"date":"Fri May 17, 2024 ","time":"4:23 PM (4 days ago)","full_date":"May 17, 2024 4:23 PM","post_time":"May 17 2024","article_id":93882307,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/labcorp-LH\/stock-news\/93882301\/form-s-8-pos-securities-to-be-offered-to-employe","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715977347,"date":"Fri May 17, 2024 ","time":"4:22 PM (4 days ago)","full_date":"May 17, 2024 4:22 PM","post_time":"May 17 2024","article_id":93882301,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});

More Labcorp News Articles

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials (2024)
Top Articles
Latest Posts
Article information

Author: Prof. Nancy Dach

Last Updated:

Views: 6193

Rating: 4.7 / 5 (77 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Prof. Nancy Dach

Birthday: 1993-08-23

Address: 569 Waelchi Ports, South Blainebury, LA 11589

Phone: +9958996486049

Job: Sales Manager

Hobby: Web surfing, Scuba diving, Mountaineering, Writing, Sailing, Dance, Blacksmithing

Introduction: My name is Prof. Nancy Dach, I am a lively, joyous, courageous, lovely, tender, charming, open person who loves writing and wants to share my knowledge and understanding with you.